Editor's Summaries of the Articles Published in This Issue of Molecular Medicine Communications
Clicks: 149
ID: 275537
2022
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
149 views
31 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #3 of 5 articles by views in Molecular Medicine Communications
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
In this issue, Riaz et al., carried out a pharmacological investigation of Carvacrol against D-galactose-induced cognitive impairment in mice, Fawad and Tahir reviewed the existing and emerging therapies in amyotrophic lateral sclerosis, Jahan and colleagues did a comparative analysis of the hepatoprotective potential of Co-enzyme Q10 as a preventive and therapeutic agent in statin-induced hepatotoxicity, Sheikh et al., reviewed studies with angiotensin-converting enzyme (ACE) inhibitors; their efficacy, adverse effects, and the genetic influence on ACE inhibitors induced cough.
| Reference Key |
staff2022moleculareditor's
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Editorial Staff; |
| Journal | Molecular Medicine Communications |
| Year | 2022 |
| DOI |
83
|
| URL | |
| Keywords |
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.